Medpace Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.2% | +2.5% | +3.3% | +1.0% | +0.6% | +4.1% | +8.0% | +9.4% | +7.4% | -0.3% | +0.1% | – | |
| – | +0.6% | -1.6% | +5.2% | -2.7% | -1.7% | +6.1% | +11.3% | +9.4% | +8.7% | +1.4% | -0.9% | – | |
| – | +2.7% | +13.4% | -0.8% | +9.9% | +5.5% | +0.0% | +0.9% | +9.4% | +4.3% | -4.4% | +2.7% | – | |
| – | -0.9% | +7.5% | -6.0% | +18.7% | -10.7% | +31.8% | -19.4% | +3.0% | -6.6% | +6.7% | +0.4% | – | |
| – | +2.5% | +3.2% | -4.7% | +16.5% | -6.7% | +22.5% | -17.2% | +2.7% | -5.6% | +5.3% | 0.0% | – | |
| – | +2.8% | +19.2% | +1.0% | +6.8% | +11.7% | -9.5% | +11.3% | +12.2% | +8.1% | -7.7% | +3.8% | – | |
| – | +1,656.2% | +123.4% | +32.6% | +37.7% | +4.7% | – | – | – | – | – | – | – | |
| – | +9.0% | +24.3% | -2.0% | +7.5% | +12.7% | -11.7% | +5.4% | +14.7% | +9.8% | -5.9% | +2.8% | – | |
| – | -1.9% | -17.9% | +117.2% | +1.0% | -24.5% | -78.8% | +858.8% | -7.5% | -31.5% | +9.3% | +27.7% | – | |
| – | +11.0% | +31.0% | -13.9% | +9.1% | +21.4% | -2.1% | -21.2% | +23.1% | +21.6% | -8.3% | -2.0% | – | |
| – | +7.0% | +24.1% | -1.7% | +7.3% | +12.0% | -11.5% | +5.2% | +13.9% | +9.4% | -5.8% | -13.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.